Furthermore, the inhibition of CXCL8 has been reported to suppress CD14+ monocyte-osteoclast differentiation in anti-cyclic citrullinated peptide antibody-positive RA [23]. The gene discussed is CXCL8; the disease is rheumatoid arthritis.